Chinese Journal of Cancer Research

Papers
(The TQCC of Chinese Journal of Cancer Research is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Esophageal cancer: Epidemiology, risk factors and screening84
Screening for gastric cancer in China: Advances, challenges and visions57
Colorectal cancer burden and trends: Comparison between China and major burden countries in the world51
Changing trends of disease burden of gastric cancer in China from 1990 to 2019 and its predictions: Findings from Global Burden of Disease Study47
Burden of liver cancer: From epidemiology to prevention38
Mn-based cGAS-STING activation for tumor therapy38
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version)33
Population-level economic burden of lung cancer in China: Provisional prevalence-based estimations, 2017−203028
Integrating pathomics with radiomics and genomics for cancer prognosis: A brief review27
Update in version 2021 of CSCO guidelines for colorectal cancer from version 202027
CSCO guidelines for colorectal cancer version 2022: Updates and discussions26
National guidelines for diagnosis and treatment of prostate cancer 2022 in China (English version)25
National guidelines for diagnosis and treatment of gastric cancer 2022 in China (English version)21
Variant rs8400 enhances ALKBH5 expression through disrupting miR-186 binding and promotes neuroblastoma progression20
Lung cancer risk in never-smokers: An overview of environmental and genetic factors20
National guidelines for diagnosis and treatment of breast cancer 2022 in China (English version)17
National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version)17
Surgical treatment of gastric cancer: Current status and future directions16
Tertiary lymphoid structure patterns predicted anti-PD1 therapeutic responses in gastric cancer14
National guidelines for diagnosis and treatment of cervical cancer 2022 in China (English version)14
Landscape of cell heterogeneity and evolutionary trajectory in ulcerative colitis-associated colon cancer revealed by single-cell RNA sequencing14
Symptom burden in advanced breast cancer patients and its association between death anxiety and psychological distress13
National guidelines for diagnosis and treatment of esophageal carcinoma 2022 in China (English version)12
Chidamide combined with cyclophosphamide, doxorubicin, vincristine and prednisone in previously untreated patients with peripheral T-cell lymphoma12
Current status of lymph node dissection in gastric cancer12
Establishment of an optimized CTC detection model consisting of EpCAM, MUC1 and WT1 in epithelial ovarian cancer and its correlation with clinical characteristics12
Contemporary trends on expenditure of hospital care on total cancer and its subtypes in China during 2008−201712
Inducing immunogenic cell death in immuno-oncological therapies12
National guidelines for diagnosis and treatment of lung cancer 2022 in China (English version)11
A radiomics prognostic scoring system for predicting progression-free survival in patients with stage IV non-small cell lung cancer treated with platinum-based chemotherapy11
Features of colorectal cancer in China stratified by anatomic sites: A hospital-based study conducted in university-affiliated hospitals from 2014 to 201811
Pan-cancer analyses demonstrate that ANKRD6 is associated with a poor prognosis and correlates with M2 macrophage infiltration in colon cancer11
Stomach cancer burden in China: Epidemiology and prevention10
Open surgery in the era of minimally invasive surgery10
Radiotherapy combined with nimotuzumab for elderly esophageal cancer patients: A phase II clinical trial10
Mitochondrial malic enzyme 2 promotes breast cancer metastasis via stabilizing HIF-1α under hypoxia10
Profiling of hepatocellular carcinoma neoantigens reveals immune microenvironment and clonal evolution related patterns10
Clinical outcomes of atezolizumab in combination with etoposide/platinum for treatment of extensive-stage small cell lung cancer: A real-world, multicenter, retrospective, controlled study in China9
Combined detection and subclass characteristics analysis of CTCs and CTECs by SE-iFISH in ovarian cancer9
Prognostic value of a modified Immunosocre in patients with stage I−III resectable colon cancer9
When immunotherapy meets liver transplantation for hepatocellular carcinoma: A bumpy but promising road9
Current status and future perspectives on neoadjuvant therapy in gastric cancer9
Molecular phenotypes reveal heterogeneous engraftments of patient-derived hepatocellular carcinoma xenografts9
National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China (English version)9
Attributable deaths of liver cancer in China9
TNFR2 is a potent prognostic biomarker for post-transplant lung metastasis in patients with hepatocellular carcinoma8
Advances in novel molecular typing and precise treatment strategies for small cell lung cancer8
Focal ablation therapy presents promising results for selectively localized prostate cancer patients8
0.027106046676636